Every Form 4 that The Gabelli Healthcare & Wellness Trust (GRX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow GRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GRX filings page.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that its 10% owner, Saba Capital Management, L.P., indirectly purchased 519 common shares on September 30, 2026, at $9.52 per share. The reported indirect position following the purchase was 2,156,552 shares. The Rule 10b5-1 checkbox was unchecked.
Gabelli Healthcare & WellnessRx Trust (GRX) reported an insider filing showing that Saba Capital Management, L.P., a ten percent owner, purchased 400 shares of Common Stock on September 11, 2026 in an open-market or private transaction at $9.71 per share, bringing its indirect holdings to 2,156,033 shares.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that major shareholder Saba Capital Management, L.P., a ten percent owner, purchased 500 shares of common stock on September 3, 2026, at $10.08 per share in an open-market or private transaction, held indirectly. Following this trade, Saba Capital’s reported indirect holdings rose to 2,155,633 shares. No Rule 10b5-1 trading plan is reported for this transaction.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 4,340 shares of common stock on August 27, 2026, in an open-market or private transaction at $10.05 per share. Following this indirect ownership purchase, Saba Capital Management reports holding 2,155,133 common shares of GRX.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 7,087 shares of Common Stock in an open-market or private transaction on 2026-08-21 at $10.13 per share. After this transaction, Saba Capital Management, L.P. indirectly holds 2,150,793 shares of GRX Common Stock.
Gabelli Healthcare & WellnessRx Trust (GRX) had a Form 4 filed reporting that Saba Capital Management, L.P., a ten percent owner, purchased 24,102 shares of GRX common stock on 2026-08-19 at $10.13 per share in an open-market or private transaction. Following this buy, Saba’s indirectly held position is reported as 2,143,706 shares. The Rule 10b5-1 checkbox was not marked, indicating the trade was not reported as pursuant to a pre-arranged trading plan.
Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a purchase of common stock. On 2026-08-14 it bought 1,203 shares at $9.86 per share in an open market or private transaction, bringing its reported indirect holdings to 2,119,604 shares.
Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported purchasing 200 shares of common stock on 2026-08-11 at $9.93 per share in an open market or private transaction. Following this indirect acquisition, Saba Capital’s reported holdings increased to 2,118,401 shares of GRX common stock.
Gabelli Healthcare & WellnessRx Trust reported insider activity involving entities associated with Mario J. Gabelli. On January 12, 2026, GGCP, Inc. purchased 3,800 common shares at $9.58 per share, bringing its reported holdings to 316,026 shares. On the same date, Associated Capital Group, Inc. purchased 1,010 common shares at $9.58, bringing its reported holdings to 10,000 shares.
The form also lists 239,425 common shares held directly, plus indirect holdings of 6,380 shares through GPJ Retirement Partners and 3,000 shares in trust accounts. Mario J. Gabelli is a director of the trust and a control person of its adviser, and the disclosure states he disclaims beneficial ownership of shares held by these entities in excess of his indirect pecuniary interest.
Gabelli Healthcare & WellnessRx Trust reported an insider transaction linked to Mario J. Gabelli, a director and control person of the adviser. On January 8, 2026, Associated Capital Group, Inc., an entity associated with him, purchased 990 common shares at $9.58 per share, bringing its reported indirect position to 8,990 shares.
Following this update, Mario J. Gabelli is reported as beneficially owning 239,425 common shares directly, and additional indirect holdings of 312,226 shares through GGCP, Inc., 6,380 shares through GPJ Retirement Partners, LLC, and 3,000 shares through a trust account, with footnotes stating he disclaims beneficial ownership beyond his indirect pecuniary interest in these entities.
Mario J. Gabelli, a director, 10% owner and control person of the adviser to Gabelli Healthcare & WellnessRx Trust, reported multiple transactions in the trust’s Series E Cumulative Preferred Shares dated 12/26/2025. The filing shows open-market or similar purchases of 1,000,000 Series E shares at $10 per share held directly, plus additional purchases of 500,000 shares through Associated Capital Group, Inc., 200,000 shares through GGCP, Inc., and 100,000 shares through MJG Associates, each at $10 per share.
The report also discloses a disposition of 200,000 Series E shares at $10 per share, described as shares surrendered under a contractual “Right to Put to the Fund” for up to 100% of the outstanding Series E preferred. Gabelli disclaims beneficial ownership of shares held by Associated Capital Group and GGCP beyond his indirect pecuniary interest.
Mario J. Gabelli reported insider transactions in Gabelli Healthcare & WellnessRx Trust Series G Cumulative Preferred Shares. On 12/26/2025, affiliates recorded a purchase of 100,000 Series G shares at $10 per share through GAMCO Investors, Inc., bringing GAMCO’s indirectly held amount to 500,000 shares. On the same date, 500,000 Series G shares were surrendered at $10 per share by Associated Capital Group, Inc. in connection with a right to put up to 100% of the outstanding Series G preferred shares to the fund, after which AC was shown with 1,500,000 shares. The filing notes Gabelli is a director, 10% owner, and control person of the adviser, and that he disclaims beneficial ownership beyond his indirect pecuniary interest in both GAMCO and AC holdings.
Gabelli Healthcare & WellnessRx Trust reporting persons associated with Saba Capital Management, L.P. disclosed open-market purchases of the fund's common stock.
On December 16, 2025, they purchased 11,312 common shares at $9.37 per share, and on December 17, 2025 they purchased an additional 4,084 shares at $9.36. Following these transactions, they beneficially owned 2,118,201 shares of common stock held indirectly.
Gabelli Healthcare & WellnessRx Trust director and adviser control person Mario J. Gabelli reported an open-market purchase of common shares. On 12/03/2025 he bought 2,500 common shares at a price of $9.6877 per share, a transaction reported as a purchase. Following this trade, he directly holds 239,425 common shares.
In addition to his direct holdings, the filing lists indirect beneficial ownership positions: 312,226 shares through GGCP, Inc., 8,000 shares through Associated Capital Group, Inc., 6,380 shares through GPJ Retirement Partners, and 3,000 shares in a trust account established by Mr. Gabelli. For several of these entities he notes that he owns less than 100% and disclaims beneficial ownership of shares beyond his indirect pecuniary interest.
Gabelli Healthcare & WellnessRx Trust director reports multiple share sales. A director of Gabelli Healthcare & WellnessRx Trust (ticker GRX) filed a Form 4 disclosing a series of open-market sales of common shares, par value $0.001, during August, September, and October 2025. Reported transactions include several sales of 2,000 shares and smaller blocks of 200 to 1,000 shares at prices around $9.1 to $9.5 per share. After these transactions, the reporting person directly beneficially owned 2,185 common shares.
Saba Capital Management, L.P., a 10% owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a recent insider purchase. On 11/25/2025, the firm bought 14,451 shares of GRX common stock in an open-market transaction coded "P" at a price of $9.62 per share. After this trade, Saba Capital Management, L.P. indirectly beneficially owned 2,102,805 GRX shares, as reported on this Form 4.
Mario J. Gabelli reported purchasing 1,800,000 Series G Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust at $10.1791 on 10/30/2025.
After the trade, reported beneficial ownership totaled 2,000,000 shares indirect via Associated Capital Group, Inc., 400,000 shares indirect via GAMCO Investors, Inc., and 200,000 shares held directly.
Gabelli Healthcare & WellnessRx Trust (GRX) reported an insider transaction on a Form 4. A reporting person purchased 20,808 shares of common stock on 10/23/2025 at a price of $9.28 per share.
Following this open-market purchase (transaction code P), the reporting person’s indirect beneficial ownership stands at 2,088,354 shares.
Gabelli Healthcare & WellnessRx Trust (GRX) reported insider activity on a Form 4. The reporting person disclosed two open‑market purchases of common stock: 6,122 shares at $9.29 on 10/21/2025 and 1,053 shares at $9.31 on 10/22/2025. Following these transactions, the reporting person beneficially owns 2,067,546 shares, held indirectly.
Gabelli Healthcare & WellnessRx Trust (GRX) reported insider activity by a 10% owner. An affiliated holder purchased common stock on two consecutive days, indicating additional accumulation.
On 10/16/2025, the holder bought 3,520 shares at $9.18. On 10/17/2025, they bought 5,816 shares at $9.20. Following these transactions, the filer reported 2,060,371 shares beneficially owned on an indirect basis. The filing is signed for Saba Capital Management, L.P. by Zachary Gindes, with Boaz Weinstein also listed.